TxCell and Trizell amend agreement to accelerate Ovasave development
24 April 2015 | By Victoria White
TxCell has announced an amendment to the Ovasave collaboration option, development and license agreement (Ovasave Agreement) with Trizell...
List view / Grid view
News
EU’s next-gen ‘healthcare heroes’ to forge ahead at European Health Parliament
24 April 2015 | By Victoria White
Young healthcare enthusiasts involved in the European Health Parliament will meet on Friday to push ahead with their ideas on Europe's future healthcare...
Batavia Bioservices changes name to Batavia Biosciences
Batavia Bioservices has changed its name to Batavia Biosciences as of 23 April 2015. The change will coincide with the launch of a new website and multimedia communication strategy.
Janssen announces results for its hepatitis C treatment simeprevir
24 April 2015 | By Victoria White
Janssen Sciences Ireland UC announced results for its hepatitis C treatment simeprevir at The International Liver Congress™ 2015...
Harvoni and Sovaldi demonstrate efficacy among chronic hepatitis C patients with advanced liver disease
23 April 2015 | By Victoria White
Results announced from several Phase 2 clinical studies evaluating uses of Harvoni and other Sovaldi-based regimens for the treatment of HCV infection...
Rising numbers of preterm births stoke demand for infant care solutions in Europe
23 April 2015 | By Victoria White
The saturated European market for infant care solutions has received fresh impetus from the rising incidence of preterm births, reports Frost & Sullivan...
New guide launched by experts to help carers identify pain in people with dementia
23 April 2015 | By Victoria White
Napp and a group of experts in the fields of pain management and dementia care have launched a training resource to help carers identify signs of pain...
Cold plasma used in world’s first clinical surgical procedure performed to selectively kill cancer tumour cells
23 April 2015 | By Victoria White
A surgical team has completed the world’s first clinical procedure using cold plasma for the selective killing of cancerous tissue...
Investigational heart failure medicine LCZ696 receives Promising Innovative Medicine designation in the UK
23 April 2015 | By Victoria White
The MHRA has granted a PIM designation for Novartis’ investigational medicine for patients with heart failure with reduced ejection fraction, LCZ696...
Mobidiag to present Novodiag and Amplidiag Easy at ECCMID 2015
23 April 2015 | By Victoria White
Mobidiag, a molecular diagnostics company, will present two new diagnostic platforms – Novodiag and Amplidiag Easy – at ECCMID 2015...
HRA Pharma to launch ellaOne (ulipristal acetate) training roadshow
23 April 2015 | By Victoria White
Now that ellaOne is available in UK Pharmacy without prescription, HRA Pharma UK is launching a training programme to support its introduction...
Bionomics initiates Phase II clinical study of BNC210 for the treatment of anxiety and depression
22 April 2015 | By Victoria White
Bionomics has initiated a Phase II clinical study of BNC210, the Company’s drug candidate in development for the treatment of anxiety and depression...
24-week clinical study strengthens the evidence of the therapeutic value of Zubsolv for maintenance treatment of opioid dependence
22 April 2015 | By Victoria White
Orexo has announced data from a trial assessing the long-term safety and efficacy of Zubsolv sublingual tablet for the treatment of opioid dependence...
Updated results from Phase 1/2 clinical trial evaluating TPI 287 for treatment of recurrent glioblastoma announced
22 April 2015 | By Victoria White
Cortice Biosciences has announced interim results a Phase 1/2 trial evaluating TPI 287 plus bevacizumab for the treatment of glioblastoma multiforme...
Merck reaffirms commitment to developing therapeutics to fight infectious diseases
22 April 2015 | By Victoria White
Merck has reaffirmed its longstanding commitment to discovering and developing novel medicines in the global fight against infectious diseases...
